1-2 of 2
Frederick Fasslrinner, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting the FMS-like Tyrosin Kinase 3 with the Unicar System: Preclinical Comparison of Murine and Humanized Single-Chain Variable Fragment-Based Targeting Modules

Frederick Fasslrinner, MD, Claudia Arndt, PhD, Anja Feldmann, PhD, Stefanie Koristka, PhD, Liliana Raquel Loureiro, PhD, Marc Schmitz, MD, Gundram Jung, MD, Martin Bornhaeuser, MD, Michael Bachmann, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5614.
https://doi.org/10.1182/blood-2019-124279
Published: 2019
Journal Articles

Long-Term Efficacy of Reduced-Intensity Conditioning Compared to Standard Myeloablative Conditioning before Allogeneic Hemopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia in First Complete Remission: 10-Year Follow-up of a Prospective, Open-Label Randomized Phase III Trial

Frederick Fasslrinner, MD, Johannes Schetelig, MD, Andreas Burchert, MD, Michael Kramer, M.Sc., Rudolf Trenschel, MD, Ute Hegenbart, Michael Stadler, MD PhD, Kerstin Schäfer-Eckart, MD, Michael Bätzel, Hans Eich, MD, Rita Engenhart-Cabillic, MD, Mechthild Krause, MD, Peter Dreger, MD, Andreas Neubauer, MD, Gerhard Ehninger, Dietrich W Beelen, MD PhD, Wolfgang E. Berdel, Timo Siepmann, MD, Matthias Stelljes, MD, Martin Bornhäuser, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4586.
https://doi.org/10.1182/blood.V130.Suppl_1.4586.4586
Published: 2017